TEST LIST
TEST LIST
TEST LIST
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Analysis Method Reference range Requirement Comments<br />
Leishmania (microscopical)<br />
Leptin<br />
microscopy punctate 1 ml<br />
RIA women 2.0 - 25.0 ng/ml<br />
men 2.0 - 15.0 ng/ml<br />
Leptospira-IgG abs. ELISA < 5 U/ml<br />
Leptospira-IgM abs. ELISA negative<br />
Leucine<br />
LC/MS see report<br />
see report<br />
see report<br />
Levetiracetam LC/MS 3.0 - 34 mg/l<br />
Levodopa<br />
Levofloxacin<br />
Levomepromazine<br />
LH (lutropin)<br />
HPLC therapeutic range 0.2 - 2.5 mg/l<br />
LC/MS toxic 5 mg/l<br />
HPLC therapeutic range 30 - 150 µg/l<br />
toxic > 500 µg/l<br />
P: Spleen or sternal punctate<br />
swab<br />
P: Swab border of lesion<br />
serum 1 ml<br />
serum 2 ml<br />
serum 2 ml<br />
EDTA-plasma 2 ml<br />
P: No serum, plasma only<br />
liquor 1 ml<br />
urine 10 ml<br />
P: Collect urine for 24 hrs. in 5-10 ml<br />
glacial acetic acid, send aliquot.<br />
serum 1 ml<br />
serum 1 ml<br />
P: Keep frozen.<br />
serum 2 ml<br />
serum 2 ml<br />
LIA women:<br />
serum 1 ml<br />
follicle phase 2.6 - 12.1 U/l<br />
Biological half-life: ca.7 hrs.<br />
Page 79